keyword
https://read.qxmd.com/read/38638439/bruton-s-tyrosine-kinase-inhibition-limits-endotoxic-shock-by-suppressing-il-6-production-by-marginal-zone-b-cells-in-mice
#21
JOURNAL ARTICLE
Kazuhiko Kawata, Shinya Hatano, Akemi Baba, Keisuke Imabayashi, Yoshihiro Baba
Sepsis is a systemic inflammatory response to a severe, life-threatening infection with organ dysfunction. Although there is no effective treatment for this fatal illness, a deeper understanding of the pathophysiological basis of sepsis and its underlying mechanisms could lead to the development of new treatment approaches. Here, we demonstrate that the selective Bruton's tyrosine kinase (Btk) inhibitor acalabrutinib augments survival rates in a lipopolysaccharide (LPS)-induced septic model. Our in vitro and in vivo findings both indicate that acalabrutinib reduces IL-6 production specifically in marginal zone B (MZ B) cells rather than in macrophages...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638433/immune-checkpoint-inhibitors-in-the-treatment-of-hepatocellular-carcinoma
#22
REVIEW
Zeynep Akbulut, Başak Aru, Furkan Aydın, Gülderen Yanıkkaya Demirel
Despite advances in cancer treatment, hepatocellular carcinoma (HCC), the most common form of liver cancer, remains a major public health problem worldwide. The immune microenvironment plays a critical role in regulating tumor progression and resistance to therapy, and in HCC, the tumor microenvironment (TME) is characterized by an abundance of immunosuppressive cells and signals that facilitate immune evasion and metastasis. Recently, anti-cancer immunotherapies, therapeutic interventions designed to modulate the immune system to recognize and eliminate cancer, have become an important cornerstone of cancer therapy...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638401/safety-and-efficacy-of-anlotinib-combined-with-taxane-and-lobaplatin-in-neoadjuvant-treatment-of-clinical-stage-ii-iii-triple-negative-breast-cancer-in-china-the-neoaltal-trial-a-single-arm-phase-2-trial
#23
JOURNAL ARTICLE
Yan Liang, Jing Liu, Jia Ge, Qiyun Shi, Guozhi Zhang, Andi Wan, Tao Luo, Hao Tian, Linjun Fan, Shushu Wang, Li Chen, Peng Tang, Kai Zhu, Jun Jiang, Xiuwu Bian, Yi Zhang, Xiaowei Qi
BACKGROUND: Anlotinib is a new type of tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors 1/2/3, platelet-derived growth factor receptors α/β, and fibroblast growth factor receptors 1-4 and c-Kit, with a broad spectrum of inhibitory effects on tumor angiogenesis and growth. It has been proven effective in HER2-negative metastatic breast cancer, but its efficacy in early-stage triple-negative breast cancer (TNBC) is unknown. This phase 2 study aims to evaluate the efficacy and safety of adding anlotinib to neoadjuvant chemotherapy in patients with TNBC...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38638365/development-of-ac2-26-mesoporous-microparticle-system-as-a-potential-therapeutic-agent-for-inflammatory-bowel-diseases
#24
JOURNAL ARTICLE
Milena Fronza Broering, Pedro Leonidas Oseliero Filho, Pâmela Pacassa Borges, Luis Carlos Cides da Silva, Marcos Camargo Knirsch, Luana Filippi Xavier, Pablo Scharf, Silvana Sandri, Marco Antonio Stephano, Fernando Anselmo de Oliveira, Ibrahim M Sayed, Lionel Fernel Gamarra, Soumita Das, Márcia C A Fantini, Sandra H P Farsky
INTRODUCTION: Inflammatory bowel diseases (IBDs) disrupt the intestinal epithelium, leading to severe chronic inflammation. Current therapies cause adverse effects and are expensive, invasive, and ineffective for most patients. Annexin A1 (AnxA1) is a pivotal endogenous anti-inflammatory and tissue repair protein in IBD. Nanostructured compounds loading AnxA1 or its active N-terminal mimetic peptides improve IBD symptomatology. METHODS: To further explore their potential as a therapeutic candidate, the AnxA1 N-terminal mimetic peptide Ac2-26 was incorporated into SBA-15 ordered mesoporous silica and covered with EL30D-55 to deliver it by oral treatment into the inflamed gut...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38636679/clinical-presentation-and-spectrum-of-gluten-symptomatology-in-celiac-disease
#25
JOURNAL ARTICLE
Dawn W Adams, Stephanie Moleski, Jacqueline Jossen, Jason A Tye-Din
Views on the clinical presentation and symptomatology of celiac disease have evolved alongside advances in disease detection and understanding of disease pathogenesis. While historically regarded a pediatric illness characterized by malabsorption, it is now better viewed as an immune illness of gluten-specific T cells with systemic manifestations affecting all ages. Its broad presentation, including frequent extraintestinal manifestations and asymptomatic disease, contributes to suboptimal disease detection...
April 16, 2024: Gastroenterology
https://read.qxmd.com/read/38636519/antibodies-targeting-the-shared-cytokine-receptor-il-1-receptor-accessory-protein-invoke-distinct-mechanisms-to-block-all-cytokine-signaling
#26
JOURNAL ARTICLE
James K Fields, Elin Jaensson Gyllenbäck, Marek Bogacz, Juliet Obi, Gabriel Svensson Birkedal, Kjell Sjöström, Kino Maravillas, Caitríona Grönberg, Sara Rattik, Kyle Kihn, Maria Flowers, Ally K Smith, Nils Hansen, Thoas Fioretos, Chau Huyhn, David Liberg, Daniel Deredge, Eric J Sundberg
Interleukin-1 (IL-1)-family cytokines are potent modulators of inflammation, coordinating a vast array of immunological responses across innate and adaptive immune systems. Dysregulated IL-1-family cytokine signaling, however, is involved in a multitude of adverse health effects, such as chronic inflammatory conditions, autoimmune diseases, and cancer. Within the IL-1 family of cytokines, six-IL-1α, IL-1β, IL-33, IL-36α, IL-36β, and IL-36γ-require the IL-1 receptor accessory protein (IL-1RAcP) as their shared co-receptor...
April 11, 2024: Cell Reports
https://read.qxmd.com/read/38636119/self-actuating-inflammation-responsive-hydrogel-microsphere-formulation-for-controlled-drug-release-in-rheumatoid-arthritis-ra-animal-trials-and-study-in-human-fibroblast-like-synoviocytes-hfls-of-ra-patients
#27
JOURNAL ARTICLE
Raghuraj Singh, Krishna Jadhav, Rohit Kamboj, Hitesh Malhotra, Eupa Ray, Agrim Jhilta, Varun Dhir, Rahul Kumar Verma
Patients with rheumatoid arthritis (RA) often have one or more painfuljoints despite adequate medicine. Local drug delivery to the synovial cavity bids for high drug concentration with minimal systemic adverse effects. However, anti-RA drugs show short half-lives in inflamed joints after intra-articular delivery. To improve the therapeutic efficacy, it is essential to ensure that a drug is only released from the formulation when it is needed. In this work, we developed an intelligent "Self-actuating" drug delivery system where Disease-modifying anti-rheumatic Drug (DMARD) methotrexate is incorporated within a matrix intended to be injected directly into joints...
April 16, 2024: Biomater Adv
https://read.qxmd.com/read/38634061/pretreatment-and-analysis-techniques-development-of-tkis-in-biological-samples-for-pharmacokinetic-studies-and-therapeutic-drug-monitoring
#28
REVIEW
Lan Chen, Yuan Zhang, Yi-Xin Zhang, Wei-Lai Wang, De-Mei Sun, Peng-Yun Li, Xue-Song Feng, Yue Tan
Tyrosine kinase inhibitors (TKIs) have emerged as the first-line small molecule drugs in many cancer therapies, exerting their effects by impeding aberrant cell growth and proliferation through the modulation of tyrosine kinase-mediated signaling pathways. However, there exists a substantial inter-individual variability in the concentrations of certain TKIs and their metabolites, which may render patients with compromised immune function susceptible to diverse infections despite receiving theoretically efficacious anticancer treatments, alongside other potential side effects or adverse reactions...
April 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38633930/sunscreen-safety-and-efficacy-for-the-prevention-of-cutaneous-neoplasm
#29
REVIEW
Jonathan R Raymond-Lezman, Suzanne I Riskin
Sunscreen is widely used for ultraviolet radiation protection. Studies validate sun protection factors (SPFs) to prevent ultraviolet (UV)-induced skin changes such as melanoma and squamous cell carcinoma (SCC). Few studies examine sunscreen's impact on endocrine and immune system dysregulation, the production of radical oxygen species, and whether the ingredients deteriorate under prolonged exposure. We present an investigation of sunscreen labels and how ingredients impact sun safety and human health. A review of the literature was conducted using Embase and PubMed to examine sunscreen safety, efficacy, and use to prevent UV-induced skin damage...
March 2024: Curēus
https://read.qxmd.com/read/38633920/influence-of-sociodemographic-factors-on-stunting-wasting-and-underweight-among-children-under-two-years-of-age-born-during-the-covid-19-pandemic-in-central-india-a-cross-sectional-study
#30
JOURNAL ARTICLE
Naina Wakode, Kushagra Bajpai, Tanwi Trushna, Santosh Wakode, Kushagra Garg, Ankur Wakode
Introduction The adverse effects of the coronavirus disease 2019 (COVID-19) pandemic on maternal and reproductive health extend beyond the immediate morbidity and mortality attributed directly to the disease. Pandemic-induced disruptions in the healthcare, social and economic infrastructures can exacerbate the already high burden of childhood undernutrition in India. Method A cross-sectional study was conducted in a selected district of the central Indian province of Madhya Pradesh. Data was collected from eligible children born during the COVID-19 pandemic (February 2020 to December 2021) who visited a selected tertiary care hospital for routine immunization during the study period...
March 2024: Curēus
https://read.qxmd.com/read/38633263/boosting-the-immunogenicity-of-the-coronavac-sars-cov-2-inactivated-vaccine-with-huoxiang-suling-shuanghua-decoction-a-randomized-double-blind-placebo-controlled-study
#31
JOURNAL ARTICLE
Ruying Tang, Linyuan Wang, Jianjun Zhang, Wenting Fei, Rui Zhang, Jinlian Liu, Meiyu Lv, Mengyao Wang, Ruilin Lv, Haipeng Nan, Ran Tao, Yawen Chen, Yan Chen, Yanxin Jiang, Hui Zhang
INTRODUCTION: In light of the public health burden of the COVID-19 pandemic, boosting the safety and immunogenicity of COVID-19 vaccines is of great concern. Numerous Traditional Chinese medicine (TCM) preparations have shown to beneficially modulate immunity. Based on pilot experiments in mice that showed that supplementation with Huoxiang Suling Shuanghua Decoction (HSSD) significantly enhances serum anti-RBD IgG titers after inoculation with recombinant SARS-CoV-2 S-RBD protein, we conducted this randomized, double-blind, placebo-controlled clinical trial aimed to evaluate the potential immunogenicity boosting effect of oral HSSD after a third homologous immunization with Sinovac's CoronaVac SARS-CoV-2 (CVS) inactivated vaccine...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38633153/immunological-effects-of-ractopamine-in-rabbits-receiving-the-viral-inactivated-rabbit-hemorrhagic-disease-vaccine
#32
JOURNAL ARTICLE
Gamal A Shams, Hosny A Ibrahim, Heba M Hassan, Nashwa S Semary, Abeer F I Hassan
BACKGROUND: There is an obvious lack of information about the effects of ractopamine, a ß-adrenergic agonist, on the growth performance and immune responses of rabbits, particularly in those receiving the viral rabbit hemorrhagic disease (RHD) vaccine. AIM: The current study was undertaken to study the effects of ractopamine on growth performances and immunological parameters in rabbits inoculated with the viral RHD vaccine. METHODS: Experimental rabbits were grouped into four groups, the first acted as a control and received distilled water, the second received ractopamine, the third received inactivated RHD vaccine, and the fourth received both ractopamine, and inactivated RHD vaccine...
January 2024: Open Veterinary Journal
https://read.qxmd.com/read/38632962/tofacitinib-for-managing-granuloma-formation-after-dermal-filler-injection-three-case-reports-and-literature-review
#33
REVIEW
Jieyi Wang, Zhuoxuan Chen, Lin Wu, Yan Liao, Bo Yu
BACKGROUND: Granuloma formation is an uncommon and persistent skin inflammatory condition caused by the injection of dermal fillers. The exact cause of this reaction is not well understood, but it may be associated with irritating components or abnormal immune function. Treating granulomas can be difficult. However, recent research has shown that Janus kinase (JAK) inhibitors hold promise as a potential therapy for refractory granulomatous diseases. OBJECTIVES: The aim was to evaluate the efficacy and safety of tofacitinib as a treatment for granulomas secondary to filler injection and the possible mechanisms were discussed and summarized...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38632657/synovium-microenvironment-responsive-injectable-hydrogel-inducing-modulation-of-macrophages-and-elimination-of-synovial-fibroblasts-for-enhanced-treatment-of-rheumatoid-arthritis
#34
JOURNAL ARTICLE
Yiqun Wu, Yu Ge, Zhongshi Wang, Ying Zhu, Tianli Tian, Jun Wei, Yu Jin, Yi Zhao, Qiang Jia, Jun Wu, Liang Ge
Rheumatoid arthritis (RA) is a progressive autoimmune disease accompanied by joint swelling, cartilage erosion and bone damage. Drug therapy for RA has been restricted due to poor therapeutic effect, recurrence and adverse effects. Macrophages and synovial fibroblasts both play important roles in the pathology of RA. Macrophages secrete large amount of pro-inflammatory cytokines, while synovial fibroblasts are tightly correlated with hypoxia synovium microenvironment, cytokine release, recruitment of pro-inflammatory cells, bone and cartilage erosion...
April 17, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38632528/immune-checkpoint-inhibitors-in-cancer-patients-with-rheumatologic-preexisting-autoimmune-diseases-a-systematic-review-and-meta-analysis
#35
Xin Liu, Su Li, Liyuan Ke, Hongxia Cui
BACKGROUND: Patients with rheumatologic preexisting autoimmune disease (PAD) have not been enrolled in clinical trials of immune checkpoint inhibitors (ICIs). Therefore, the risks and benefits of ICI therapy in such patients are unclear. Herein, we investigated the safety and efficacy of ICIs in rheumatologic PAD patients through a meta-analysis. METHODS: The PubMed, Cochrane Library, Embase and Web of Science databases were searched for additional studies. We analyzed the following data through Stata software: incidence of total irAEs (TirAEs), rate of flares, incidence of new on-set irAEs, rate of discontinuation, objective response rate (ORR) and disease control rate (DCR)...
April 17, 2024: BMC Cancer
https://read.qxmd.com/read/38631708/preclinical-evaluation-and-first-in-dog-clinical-trials-of-pbmc-expanded-natural-killer-cells-for-adoptive-immunotherapy-in-dogs-with-cancer
#36
JOURNAL ARTICLE
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
BACKGROUND: Natural killer (NK) cells are cytotoxic cells capable of recognizing heterogeneous cancer targets without prior sensitization, making them promising prospects for use in cellular immunotherapy. Companion dogs develop spontaneous cancers in the context of an intact immune system, representing a valid cancer immunotherapy model. Previously, CD5 depletion of peripheral blood mononuclear cells (PBMCs) was used in dogs to isolate a CD5dim -expressing NK subset prior to co-culture with an irradiated feeder line, but this can limit the yield of the final NK product...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631628/meta-analysis-unravels-the-complex-combined-toxicity-of-microplastics-and-antibiotics-in-aquatic-ecosystems
#37
JOURNAL ARTICLE
Ziyue Yu, Qiuying An, Tong Zhou, Li Zhou, Bing Yan
The aquatic ecosystem, a repository for various pollutants, has been identified as a crucial zone where microplastics (MPs) serve as vectors for antibiotics, facilitating their spread. Despite this, the influence of MPs on the toxicity of antibiotics remains a topic of debate. In this study, we conduct a global meta-analysis, examining 730 datasets from 29 laboratory studies. Our findings reveal that the impact of MPs on antibiotic toxicity is highly dependent on biological response pathways, microplastic concentration, antibiotic properties, and exposure time...
April 15, 2024: Science of the Total Environment
https://read.qxmd.com/read/38631522/prospective-multi-centre-head-to-head-comparison-between-allergists-vs-non-allergists-in-low-risk-penicillin-allergy-delabelling-effectiveness-safety-and-quality-of-life-hk-dadi2
#38
JOURNAL ARTICLE
Jane Cy Wong, Andy Kc Kan, Thomas Sh Chik, M Y Chu, Timothy Cm Li, Hugo Wf Mak, Valerie Chiang, Philip H Li
BACKGROUND: Penicillin "allergy" labels are prevalent but frequently misdiagnosed. Mislabelled allergies are associated with adverse outcomes and increased antimicrobial resistance. With an urgent need to delabel the overwhelming number of mislabelled allergies, non-allergist evaluations have been advocated for low-risk individuals. Despite growing interest in non-allergist-led initiatives; evidence on their effectiveness, safety, and impact by direct comparisons are lacking. OBJECTIVE: We assessed the comparative outcomes of penicillin allergy evaluations conducted by allergists vs...
April 15, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38631324/quality-of-life-impact-in-patients-with-cutaneous-toxicities-caused-by-egfr-inhibitors-and-immunotherapy
#39
JOURNAL ARTICLE
Maria Mannino, Pietro Sollena, Alessandro Di Stefani, Ernesto Rossi, Ettore D'Argento, Giovanni Schinzari, Giampaolo Tortora, Ketty Peris
BACKGROUND: novel oncologic therapies, including epidermal growth factor receptor inhibitors (EGFR-Is) and immune checkpoint inhibitors (ICIs), are associated with a new spectrum of adverse reactions, with prominent cutaneous toxicities. The impact of cutaneous adverse events (cAEs) on patients' quality of life (QoL) represents an unmet clinical need. OBJECTIVES: 1) to assess whether cutaneous toxicities directed therapies are effective in reducing the QoL burden via the submission of two patient reported outcome measures (PROMs); 2) to investigate whether class of oncologic therapy, type of cAE and toxicity severity differently impact on patients' QoL...
April 17, 2024: Dermatology: International Journal for Clinical and Investigative Dermatology
https://read.qxmd.com/read/38629741/long-term-efficacy-and-safety-of-tailored-immunosuppressive-therapy-in-immune-mediated-biopsy-proven-myocarditis-a-propensity-weighted-study
#40
JOURNAL ARTICLE
Alida Linda Patrizia Caforio, Andrea Silvio Giordani, Anna Baritussio, Davide Marcolongo, Cristina Vicenzetto, Giuseppe Tarantini, Massimo Napodano, Giuseppe Toscano, Dario Gregori, Gloria Brigiari, Patrizia Bartolotta, Elisa Carturan, Monica De Gaspari, Stefania Rizzo, Cristina Basso, Sabino Iliceto, Renzo Marcolongo
AIMS: Standardized immunosuppressive therapy (IS) had been previously investigated in biopsy-proven (BP) lymphocytic myocarditis with heart failure (HF). This study evaluated efficacy and safety of tailored IS in BP immune-mediated myocarditis, irrespective of histology and clinical presentation. METHODS AND RESULTS: Consecutive BP myocarditis patients treated with long-term tailored IS on top of optimal medical therapy (OMT), were compared with OMT non-IS controls using propensity-score weighting...
April 17, 2024: European Journal of Heart Failure
keyword
keyword
86469
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.